Neurava
PrivateLast Round
Grant
Apr 23, 2026
Total Funding Raised
$6.96M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neurava is a medical technology company that develops wearable diagnostic devices to monitor and alert for seizures and cardiorespiratory dysfunctions in patients with epilepsy to mitigate the risk of SUDEP.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Sensors
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Subscription SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurava Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Neurava Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 23, 2026 | ||||
| Seed | Apr 3, 2024 | ||||
| Seed | Nov 1, 2021 | ||||
| Grant | Apr 9, 2021 | ||||
| Pre Seed | Dec 19, 2019 |
Key People
Founding team and executive leadership
Neurava Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rivermount Ventures | Seed |
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| Elevate Ventures | Seed, Pre Seed |
| iO Life Ventures | Seed |
| UCB Ventures | Seed |
| SWPDC | Grant |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 76% MoM, reaching 2.7K.
- Apr 26, 2026
Grew 60% QoQ from 5 to 8 employees.
Neurava Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurava's valuation, stock price, and market status.